CLLS:NASDAQ
Cellectis SA
$3.24
arrow_downward
-2.41%(-0.080) 1D
Sep 4, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CLLS...
Open
$3.41
High
$3.41
Low
$3.21
Mkt. cap
241.09M
Avg. vol.
17.09K
Volume
4.83K
52-wk high
$5.48
52-wk low
$2.35
EPS
-$0.65
Beta
2.92
Shares outstanding
72.09M
No. of employees
227
Open
$3.41
High
$3.41
Low
$3.21
Mkt. cap
241.09M
Avg. vol.
17.09K
Volume
4.83K
52-wk high
$5.48
52-wk low
$2.35
EPS
-$0.65
Beta
2.92
Shares outstanding
72.09M
No. of employees
227
News stories
From web sources and news partners
Kalkine Media
·
1 day ago
Cellectis (NASDAQ:CLLS): Is Its Latest Rally More Than Technical?
Stock Titan
·
2 days ago
Cellectis has more voting rights than shares
Profile
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia
About Cellectis SA